Allahabadi Sachin, Quigley Ryan, Frazier Landon, Joyce Kaitlyn, Cole Brian J
Midwest Orthopaedics at Rush University Medical Center, Chicago, Illinois, USA.
Orthop J Sports Med. 2024 Feb 26;12(2):23259671241226738. doi: 10.1177/23259671241226738. eCollection 2024 Feb.
Limited data are available on the outcomes and return-to-sport rates after osteochondral allograft transplant in professional athletes.
To evaluate the experience of a single senior surgeon in treating professional athletes with osteochondral allograft transplant, including analyzing clinical outcomes and return to sport.
Case series; Level of evidence, 4.
The authors performed a retrospective review of professional athletes treated with primary osteochondral allograft to the knee between January 1, 2001, and January 1, 2021, by a single surgeon. Athletes were required to play at the professional level in their sport and have a minimum of 2 years of follow-up. Return-to-sport rates and timing were evaluated. Patient-reported outcomes were assessed preoperatively and at final follow-up. Reoperations and failures were also tabulated.
The study included 15 professional athletes who represented a variety of sports, with follow-up at a mean of 4.91 ± 2.2 years (range, 2.0-9.4 years). The majority (8 athletes; 53%) had undergone prior surgeries to the operative knee. Eleven (73%) returned to sport at a mean of 1.22 ± 0.4 years (range, 0.75-2 years), and of the 8 undergoing isolated osteochondral allograft, 7 (87.5%) returned at 1.28 ± 0.3 years. Ten athletes (66.7% of total; 90.9% of those who returned) returned to sport at the same level or higher compared with before surgery. Significant improvements were seen in each assessed patient-reported outcome score at final follow-up. Two of the 3 (66.7%) patients who underwent concomitant meniscal allograft transplant were able to return to sport at the same level or higher than presurgery. Three (20%) underwent second-look arthroscopy, 1 (6.7%) of whom underwent cartilage debridement of the osteochondral allograft.
Osteochondral allograft transplant in professional athletes can result in a high rate of return to play at a similar or higher level as presurgery, even when performed with concomitant procedures such as meniscal allograft transplant. High-level athletes should expect significant postoperative improvement in clinical outcomes.
关于职业运动员接受同种异体骨软骨移植后的疗效和重返运动率的数据有限。
评估一位资深外科医生治疗职业运动员同种异体骨软骨移植的经验，包括分析临床疗效和重返运动情况。
病例系列；证据等级，4级。
作者对2001年1月1日至2021年1月1日期间由同一位外科医生进行初次膝关节同种异体骨软骨移植治疗的职业运动员进行了回顾性研究。运动员需在其运动项目中达到职业水平且至少随访2年。评估重返运动率和时间。术前及末次随访时评估患者报告的结局。记录再次手术和失败情况。
该研究纳入了15名代表多种运动项目的职业运动员，平均随访时间为4.91±2.2年（范围2.0 - 9.4年）。大多数（8名运动员；53%）手术膝关节此前接受过手术。11名（73%）运动员平均在1.22±0.4年（范围0.75 - 2年）后重返运动，在8名单独接受同种异体骨软骨移植的运动员中，7名（87.5%）在1.28±0.3年时重返运动。10名运动员（占总数的66.7%；在重返运动的运动员中占90.9%）与术前相比，以相同或更高水平重返运动。末次随访时，每个评估的患者报告结局评分均有显著改善。3名接受同种异体半月板移植的患者中有2名（66.7%）能够以相同或高于术前的水平重返运动。3名（20%）患者接受了二次关节镜检查，其中1名（6.7%）对同种异体骨软骨移植进行了软骨清创。
职业运动员同种异体骨软骨移植即使与同种异体半月板移植等联合手术一起进行，也能使运动员以与术前相似或更高的水平重返运动的比例很高。高水平运动员术后临床疗效应会有显著改善。
